Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 13 studies. IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children DAIDS Number 12016 Research Area Complications & Comorbidities Study Status Concluded P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded P1055: Psychiatric Co-Morbidity in Perinatally-Infected Children. DAIDS Number 10049 Research Area Other Study Status Concluded P1052: Abacavir PK Study in HIV-1 Infected Adolescents and Young Adults DAIDS Number 10194 Research Area Other Study Status Concluded P1036B: Directly Observed Therapy in HIV-Infected Adolescents DAIDS Number 10044 Research Area Other Study Status Concluded P1022: PI Including vs. PI-Sparing Regimen in Women During Pregnancy DAIDS Number 10192 Research Area Other Study Status Concluded P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded P1018: Single Dose Pk Study of Abacavir in HIV-Infected Children and Adolescents DAIDS Number 10268 Research Area Other Study Status Concluded Pagination Current page 1 Page 2 Next page Next
IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children DAIDS Number 12016 Research Area Complications & Comorbidities Study Status Concluded
P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded
P1076: Impact of Oral Alendronate Therapy on BMD in HIV-Infected Children/Adolescents DAIDS Number 10669 Research Area Complications & Comorbidities Study Status Concluded
P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers DAIDS Number 10638 Research Area Complications & Comorbidities Study Status Concluded
P1055: Psychiatric Co-Morbidity in Perinatally-Infected Children. DAIDS Number 10049 Research Area Other Study Status Concluded
P1052: Abacavir PK Study in HIV-1 Infected Adolescents and Young Adults DAIDS Number 10194 Research Area Other Study Status Concluded
P1036B: Directly Observed Therapy in HIV-Infected Adolescents DAIDS Number 10044 Research Area Other Study Status Concluded
P1022: PI Including vs. PI-Sparing Regimen in Women During Pregnancy DAIDS Number 10192 Research Area Other Study Status Concluded
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
P1018: Single Dose Pk Study of Abacavir in HIV-Infected Children and Adolescents DAIDS Number 10268 Research Area Other Study Status Concluded
